The concept lab will be a shared laboratory that offers entrepreneurs affordable access to single bench spaces to perform early stage research before committing additional capital. The open collaboration space will be an open-plan office setting that provides companies and individuals with desk space in an environment that facilitates interactions with other life-science entrepreneurs. With these additions, Janssen Labs will be able to accommodate more than double the number of companies as when it opened.
These new offerings provide accessible, economical options for entrepreneurs to get to a preclinical proof-of-concept by leveraging big company infrastructure, equipment and resources. Companies and individuals within the concept lab and the open collaboration space will have access to the same amenities provided in the original Janssen Labs model, including more than 70 pieces of common equipment, as well as essential laboratory infrastructure, such as fume hoods, refrigeration, emergency power, emergency shower/eyewash, conference rooms and high-speed internet. The “no-strings-attached” model applies to all companies and individuals residing at Janssen Labs.
“In the year since we opened, Janssen Labs has shown to be a place where emerging companies thrive. With the addition of the concept lab and open collaboration space, we now can welcome additional scientists and tech entrepreneurs who will bring unique perspectives that can enrich our life science community,” said Diego Miralles, M.D., head of Janssen West Coast Research Center. “We are confident that the important work taking place within the labs and offices of this collaborative environment will serve patients worldwide by delivering novel solutions to significant unmet medical needs.”
The entrepreneurs utilizing the concept lab and the open collaboration space will be able to quickly begin their work in a capital-efficient manner and have the flexibility to move into a larger, private space at Janssen Labs when they require a larger footprint.
Janssen Labs currently houses 18 companies pursing novel technologies in the life sciences, including therapeutics, medical devices, diagnostics, tools and instrumentation.
